Model formation of future teachers readiness to innovative activity

The relevance of the study is justified by the new requirements for the personality of a specialist in the field of education. Thus, an obligatory component of professional and pedagogical competence is the innovative competence of the teacher. The formation of this competence in future teachers in the system of their professional training in higher education requires special methodological system of innovative competence formation. The purpose of this article is to reveal the essence and to describe the model of readiness to innovative activity of future teachers. The purpose of the article is realized by applying theoretical (spectral analysis, generalization) and empirical (modeling, methods of pedagogical diagnostics) methods of scientific knowledge in the research. On the basis of the application of these methods in the study, the essence, features and structure of pedagogical innovative activity are determined. The necessity of innovative activity readiness formation of future teachers is substantiated. The components of the structure of teacher's readiness for innovative activity are described. The essence of pedagogical formation model of future teachers readiness to innovative activity is described. Its efficiency on the basis of quantitative and qualitative results is proved. The elements of scientific novelty in the work are represented by the creation of an experimental pedagogical model of the formation of the future teachers’ readiness to innovative activity, the substantiation of methodological and methodical aspects of its implementation, the development of the criteria base for determining the level of formation of the future teachers’ readiness to innovative activity

High-risk patients: modern treatment strategy

This review summarizes modern views on high-risk patients as atherosclerosis-free individuals. The importance of high-risk approach is explained by the fact that this group encompasses the majority of cardiac patients, as well as the majority of cardiovascular events. Therefore, early diagnostics and adequate management of high-risk patients could substantially reduce the incidence of cardiovascular events. The modern treatment strategy for high-risk patients requires pharmaceutical intervention, and has the same principles as the treatment of patients with diagnosed cardiovascular disease. Such components of pharmaceutical treatment as antihypertensive, lipidlowering, and anti-aggregant therapy are discussed in detail

Beta-adrenoblockers in clinical practice: is there any difference?

Modern views on various β-adrenoblockers (BB) place in clinical practice are presented. BB class is a clinically heterogeneous group. Recent criticism of BB should not disorient practitioners, who must understand which BB are mentioned. Some BB, mostly non-selective, demonstrate adverse effects and cannot be used in certain clinical situations: metabolic disturbances, chronic obstructive pulmonary disease (COPD), peripheral artery atherosclerosis. At the same time, modern super-selective BB are safe and can be administered even in individuals with metabolic syndrome, diabetes mellitus, COPD, or peripheral artery atherosclerosis

Arterial hypertension therapy effectiveness in smokers

The review briefly describes the studies on cardiac agents’ effectiveness in smoking patients. Various antihypertensive classes might have different effects in smoking individuals with arterial hypertension (AH). In such patients, medications improving endothelial function might be more effective. At the same time, more evidence is needed to compare various antihypertensive classes’ effectiveness in smokers